Abstract
Activating transcription factor 2(ATF2), a transcription factor belonging to the AP-1 family, plays an important role in inflammation. However, its biological functions and underlying molecular mechanisms in rheumatoid arthritis (RA) remain unclear. Western blot and immunohistochemistry were used to identify the expression of ATF2 and Sprouty2(SPRY2) in RA synovial tissues. SW982 cells were stimulated by TNF-α to establish an in vitro RA fibroblast-like synoviocyte (RA-FLS) model. Transwell and monolayer wound-healing were used to detect cell migration and invasion. RNA interference (si-ATF2) and adenovirus vector (Ad-SPRY2) methods were employed to manipulate ATF2 or SPRY2 expression in SW982 cells. The protein expression and phosphorylation levels in SW982 cells were evaluated by western blot. ATF2 expression and phosphorylation were upregulated in the RA synovial tissues. In RA-FLS model, ATF2 expression and phosphorylation were increased in a time-dependent manner. ATF2 knockdown inhibited the migration and invasion of RA-FLS model, reducing the inflammatory factors, which was consistent with the influence on cell behaviors caused by SPRY2 overexpression. Moreover, SPRY2 overexpression inhibited the TNF-α-induced phosphorylation of ERK and ATF2 in SW982 cells. The high expression and phosphorylation of ATF2 promoted migration and invasion of RA-FLSs. SPRY2 might inhibited the inflammatory responses of RA-FLSs via suppressing ERK-ATF2 pathway.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10753-020-01311-z/MediaObjects/10753_2020_1311_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10753-020-01311-z/MediaObjects/10753_2020_1311_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10753-020-01311-z/MediaObjects/10753_2020_1311_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10753-020-01311-z/MediaObjects/10753_2020_1311_Fig4_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10753-020-01311-z/MediaObjects/10753_2020_1311_Fig5_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10753-020-01311-z/MediaObjects/10753_2020_1311_Fig6_HTML.png)
Similar content being viewed by others
References
Okada, Y., D. Wu, G. Trynka, T. Raj, C. Terao, K. Ikari, Y. Kochi, K. Ohmura, A. Suzuki, S. Yoshida, R.R. Graham, and A. Manoharan. 2014. Genetics of rheumatoid arthritis contributes to biology and drug discovery[J]. Nature 506 (7488): 376–381.
Källberg, H., B. Ding, L. Padyukov, C. Bengtsson, J. Rönnelid, L. Klareskog, and L. Alfredsson. 2011. Null null. Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke[J]. Annals of the Rheumatic Diseases 70 (3): 508–511.
Konig, M.F., L. Abusleme, J. Reinholdt, R.J. Palmer, R.P. Teles, K. Sampson, A. Rosen, P.A. Nigrovic, J. Sokolove, and J.T. Giles. 2016. Aggregatibacter actinomycetemcomitans-induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis[J]. Science Translational Medicine 8: 369ra176.
McInnes, I.B., and G. Schett. 2017. Pathogenetic insights from the treatment of rheumatoid arthritis[J]. Lancet 389: 2328–2337.
Ganesan, R., and M. Rasool. 2017. Fibroblast-like synoviocytes-dependent effector molecules as a critical mediator for rheumatoid arthritis: Current status and future directions[J]. International Reviews of Immunology 36 (1): 20–30.
Agere, S.A., N. Akhtar, J.M. Watson, and S. Ahmed. 2017. RANTES/CCL5 induces collagen degradation by activating MMP-1 and MMP-13 expression in human rheumatoid arthritis synovial fibroblasts [J]. Frontiers in Immunology 8: 1341.
Zou, Y., S. Zeng, M. Huang, Q. Qiu, Y. **ao, M. Shi, Z. Zhan, L. Liang, X. Yang, and H. Xu. 2017. Inhibition of 6-phosphofructo-2-kinase suppresses fibroblast-like synoviocytes-mediated synovial inflammation and joint destruction in rheumatoid arthritis[J]. British Journal of Pharmacology 174 (9): 893–908.
Wang, H., S. Tu, S. Yang, P. Shen, Y. Huang, X. Ba, W. Lin, Y. Huang, Y. Wang, K. Qin, Chen Z. Berberine, and L.P.A. Modulates. 2019. Function to inhibit the proliferation and inflammation of FLS-RA via p38/ERK MAPK Pathway Mediated by LPA[J]. Evidence-based Complementary and Alternative Medicine: Ecam 2019: 2580207.
Guo, X., D. Zhang, X. Zhang, J. Jiang, P. Xue, C. Wu, J. Zhang, G. **, Z. Huang, J. Yang, X. Zhu, W. Liu, G. Xu, Z. Cui, and G. Bao. 2018. Dyrk1 A promotes the proliferation, migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis via down-regulating Spry2 and activating the ERK MAPK pathway[J]. Tissue & Cell 54: 63–70.
Shuang, F., Y. Zhou, S.X. Hou, J.L. Zhu, Y. Liu, C.L. Zhang, and J.G. Tang. 2015. Indian hedgehog signaling pathway members are associated with magnetic resonance imaging manifestations and pathological scores in lumbar facet joint osteoarthritis[J]. Scientific Reports 5: 10290.
Zhao, Q., S. Chen, Z. Zhu, L. Yu, Y. Ren, M. Jiang, J. Weng, and B. Li. 2018. miR-21 promotes EGF-induced pancreatic cancer cell proliferation by targeting Spry2[J]. Cell Death & Disease 9 (12): 1157.
Xu, Y.F., H.D. Liu, Z.L. Liu, C. Pan, X.Q. Yang, S.L. Ning, Z.L. Zhang, S. Guo, and J.M. Yu. 2018. Sprouty2 suppresses progression and correlates to favourable prognosis of intrahepatic cholangiocarcinoma via antagonizing FGFR2 signalling[J]. Journal of Cellular and Molecular Medicine 22 (11): 5596–5606.
Zhang, W., Z. Du, J. Zhu, J. Yu, and Y. Xu. 2015. Sprouty2 suppresses the inflammatory responses in rheumatoid arthritis fibroblast-like synoviocytes through regulating the Raf/ERK and PTEN/AKT signals[J]. Molecular Immunology 67 (2 Pt B): 532–539.
Watson, G., Z.A. Ronai, and E. Lau. 2017. ATF2, a paradigm of the multifaceted regulation of transcription factors in biology and disease[J]. Pharmacological Research 119: 347–357.
Li, X.Y., and M.R. Green. 1996. Intramolecular inhibition of activating transcription factor-2 function by its DNA-binding domain[J]. Genes & Development 10 (5): 517–527.
Zhang, R., H. Luo, S. Wang, Z. Chen, L. Hua, H.W. Wang, W. Chen, Y. Yuan, X. Zhou, D. Li, S. Shen, T. Jiang, Y. You, N. Liu, and H. Wang. 2015. MiR-622 suppresses proliferation, invasion and migration by directly targeting activating transcription factor 2 in glioma cells[J]. Journal of Neuro-Oncology 121 (1): 63–72.
Wu, D.S., C. Chen, Z.J. Wu, B. Liu, L. Gao, Q. Yang, W. Chen, J.M. Chen, Y. Bao, L. Qu, and L.H. Wang. 2016. ATF2 predicts poor prognosis and promotes malignant phenotypes in renal cell carcinoma[J]. Journal of Experimental & Clinical Cancer Research: CR 35 (1): 108.
Li, M., D. Zhang, X. Ge, X. Zhu, Y. Zhou, Y. Zhang, X. Peng, and A. Shen. 2019. TRAF6-p38/JNK-ATF2 axis promotes microglial inflammatory activation[J]. Experimental Cell Research 376 (2): 133–148.
Li, B., N. Li, L. Zhang, K. Li, Y. **e, M. Xue, and Z. Zheng. 2018. Hsa_circ_0001859 regulates ATF2 expression by functioning as an MiR-204/211 sponge in human rheumatoid arthritis[J]. Journal of Immunology Research 2018: 9412387.
Poolman, T.M., J. Gibbs, A.L. Walker, S. Dickson, L. Farrell, J. Hensman, A.C. Kendall, R. Maidstone, S. Warwood, and A. Loudon. 2019. Rheumatoid arthritis reprograms circadian output pathways[J]. Arthritis Research & Therapy 21 (1): 47.
Pfeifle, R., T. Rothe, N. Ipseiz, H.U. Scherer, S. Culemann, U. Harre, J.A. Ackermann, M. Seefried, A. Kleyer, and S. Uderhardt. 2017. Regulation of autoantibody activity by the IL-23-T17 axis determines the onset of autoimmune disease[J]. Nature Immunology 18 (1): 104–113.
Fessler, J., R. Husic, V. Schwetz, E. Lerchbaum, F. Aberer, P. Fasching, A. Ficjan, B. Obermayer-Pietsch, C. Duftner, and W. Graninger. 2018. Senescent T-cells promote bone loss in rheumatoid arthritis[J]. Frontiers in Immunology 9: 95.
Wu, S., Y. Li, L. Yao, Y. Li, S. Jiang, W. Gu, H. Shen, L. **a, and J. Lu. 2018. Interleukin-35 inhibits angiogenesis through STAT1 signalling in rheumatoid synoviocytes[J]. Clinical and Experimental Rheumatology 36 (2): 223–227.
Zeke, A., M. Misheva, A. Reményi, and M.A. Bogoyevitch. 2016. JNK signaling: regulation and functions based on complex protein-protein partnerships[J]. Microbiology and Molecular Biology Reviews 80 (3): 793–835.
Colomb, F., M.A. Krzewinski-Recchi, A. Steenackers, A. Vincent, A. Harduin-Lepers, P. Delannoy, and S. Groux-Degroote. 2017. TNF up-regulates ST3GAL4 and sialyl-Lewisx expression in lung epithelial cells through an intronic ATF2-responsive element[J]. The Biochemical Journal 474 (1): 65–78.
Tang, J., Y. Liao, S. He, J. Shi, L. Peng, X. Xu, F. **e, N. Diao, J. Huang, Q. **e, C. Lin, X. Luo, K. Liao, J. Ma, J. Li, D. Zhou, and Z. Li. 2017. Autocrine parathyroid hormone-like hormone promotes intrahepatic cholangiocarcinoma cell proliferation via increased ERK/JNK-ATF2-cyclinD1 signaling[J]. Journal of Translational Medicine 15 (1): 238.
Inoue, S., T. Mizushima, H. Ide, G. Jiang, T. Goto, Y. Nagata, G.J. Netto, and H. Miyamoto. 2018. ATF2 promotes urothelial cancer outgrowth via cooperation with androgen receptor signaling[J]. Endocrine Connections 7 (12): 1397–1408.
**ao, Y., Y. Lu, Y. Wang, W. Yan, and W. Cai. 2019. Deficiency in intestinal epithelial Reg4 ameliorates intestinal inflammation and alters the colonic bacterial composition[J]. Mucosal Immunology 12 (4): 919–929.
Yigzaw, Y., L. Cartin, S. Pierre, K. Scholich, and T.B. Patel. 2001. The C terminus of sprouty is important for modulation of cellular migration and proliferation[J]. The Journal of Biological Chemistry 276: 22742–22747.
Feng, Y.H., C.L. Wu, C.J. Tsao, J.G. Chang, P.J. Lu, K.T. Yeh, Y.H. Uen, J.C. Lee, and A.L. Shiau. 2011. Deregulated expression of sprouty2 and microRNA-21 in human colon cancer: Correlation with the clinical stage of the disease[J]. Cancer Biology & Therapy 11: 111–121.
Gao, M., R. Patel, I. Ahmad, J. Fleming, J. Edwards, S. McCracken, K. Sahadevan, M. Seywright, J. Norman, O. Sansom, and H.Y. Leung. 2012. SPRY2 loss enhances ErbB trafficking and PI3K/AKT signalling to drive human and mouse prostate carcinogenesis[J]. EMBO Molecular Medicine 4: 776–790.
Patel, R., M. Gao, I. Ahmad, J. Fleming, L.B. Singh, T.S. Rai, A.B. McKie, M. Seywright, R.J. Barnetson, J. Edwards, O.J. Sansom, and H.Y. Leung. 2013. Sprouty2, PTEN, and PP2A interact to regulate prostate cancer progression[J]. The Journal of Clinical Investigation 123: 1157–1175.
Shukla, A., K. Rai, V. Shukla, N.K. Chaturvedi, R.G. Bociek, S.J. Pirruccello, H. Band, R. Lu, and S.S. Joshi. 2016. Sprouty2: A novel attenuator of B-cell receptor and MAPK-Erk signaling in CLL[J]. Blood 127 (19): 2310–2321.
He, Y., Y. Ge, M. Jiang, J. Zhou, D. Luo, H. Fan, L. Shi, L. Lin, and L. Yang. 2018. MiR-592 promotes gastric cancer proliferation, migration, and invasion through the PI3K/AKT and MAPK/ERK signaling pathways by targeting Spry2[J]. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology 47 (4): 1465–1481.
Saha, B., J.C. Bruneau, K. Kodys, and G. Szabo. 2015. Alcohol-induced miR-27a regulates differentiation and M2 macrophage polarization of normal human monocytes[J]. Journal of Immunology (Baltimore, Md. : 1950) 194 (7): 3079–3087.
Zhang, W., J. Zhu, Z. Du, J. Yu, Y. Xu, and F. Wang. 2015. Intraarticular gene transfer of SPRY2 suppresses adjuvant-induced arthritis in rats[J]. Applied Microbiology and Biotechnology 99 (16): 6727–6735.
Funding
This work was supported by the National Natural Science Foundation of China (81702216), Scientific Research Project of “333 Project” in Jiangsu Province (BRA2018224), Nantong Science and Technology Project (JC2019031), Scientific Research Project of Health Commission of Jiangsu Province (H2018035).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Fig. S1
SW982 cells were transfected with si-ATF2#1, and si-Ctrl was used as a negative control. a Western blot confirmed that inhibition of ATF2 reduced the protein expression of MMP-13 and IL-1β in SW982 cells stimulated by TNF-α (10ng/ml). b ELISA indicated that ATF2 inhibition can effectively reduce the level of IL-6 in SW982 cell supernatant, with or without TNF-α stimulation. c The monolayer wound-healing assay was used to access the migration ability of SW982 cells. d The invasion assay was carried out in a Matrigel basement membrane matrix chamber. All values represent the mean ± SD, *P<0.05 vs control. (JPG 2.91 mb)
Rights and permissions
About this article
Cite this article
Zhang, X., Zhang, D., Wang, Q. et al. Sprouty2 Inhibits Migration and Invasion of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis by Down-regulating ATF2 Expression and Phosphorylation. Inflammation 44, 91–103 (2021). https://doi.org/10.1007/s10753-020-01311-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-020-01311-z